Travoprost Patent Expiration

Travoprost was first introduced by Alcon Pharmaceuticals Ltd in its drug Travatan on Mar 16, 2001. Other drugs containing Travoprost are Travatan Z, Idose Tr, Izba. 10 different companies have introduced drugs containing Travoprost.


Travoprost Patents

Given below is the list of patents protecting Travoprost, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Idose Tr US10206813 Implants with controlled drug delivery features and methods of using same Oct 17, 2030 Glaukos
Idose Tr US11426306 Implants with controlled drug delivery features and methods of using same Oct 17, 2030 Glaukos
Izba US8178582 Pharmaceutical compositions having desirable bioavailability Oct 10, 2029 Novartis
Izba US8722735 Pharmaceutical compositions having desirable bioavailability Oct 10, 2029 Novartis
Izba US8754123 Pharmaceutical compositions having desirable bioavailability May 19, 2029 Novartis
Izba US9144561 Pharmaceutical compositions having desirable bioavailability Mar 13, 2029 Novartis
Travatan US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension Aug 03, 2013

(Expired)

Alcon Pharms Ltd
Travatan US5631287 Storage-stable prostaglandin compositions Dec 22, 2014

(Expired)

Alcon Pharms Ltd
Travatan US5849792 Storage-stable prostaglandin compositions Dec 22, 2014

(Expired)

Alcon Pharms Ltd
Travatan US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Dec 02, 2014

(Expired)

Alcon Pharms Ltd
Travatan US6011062 Storage-stable prostaglandin compositions Dec 22, 2014

(Expired)

Alcon Pharms Ltd
Travatan Z US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension Aug 03, 2013

(Expired)

Sandoz
Travatan Z US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Dec 02, 2014

(Expired)

Sandoz
Travatan Z US8268299 Self preserved aqueous pharmaceutical compositions Oct 13, 2029 Sandoz
Travatan Z US8323630 Self-preserved aqueous pharmaceutical compositions Sep 20, 2027 Sandoz
Travatan Z US8388941 Self preserved aqueous pharmaceutical compositions Sep 20, 2027 Sandoz


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Travoprost Generics

Several generic applications have been filed for Travoprost. The first generic version for Travoprost was by Chartwell Rx Sciences Llc and was approved on Mar 1, 2013. And the latest generic version is by Lupin Ltd and was approved on May 3, 2024.

Given below is the list of companies who have filed for Travoprost generic.


1. LUPIN LTD

Lupin Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004% solution/drops Prescription OPHTHALMIC AT May 3, 2024


2. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004% solution/drops Prescription OPHTHALMIC AT1 Dec 20, 2019


3. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004% solution/drops Prescription OPHTHALMIC AT Jul 7, 2017


4. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004%

(reference standard)

solution/drops Prescription OPHTHALMIC AT1 Mar 1, 2013


5. APOTEX

Apotex Inc has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004% solution/drops Prescription OPHTHALMIC AT Jul 10, 2015


6. MICRO LABS

Micro Labs Ltd has filed for 1 generic for Travoprost. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.004% solution/drops Prescription OPHTHALMIC AT Mar 19, 2021